Ovarian, Stage III-IV Clear Cell
GOG 0268: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Cancer
Ovarian, Primary Peritoneal, or Fallopian Tube, Recurrent
GOG 213: Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
GOG 0186-K: Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
For more information, contact Cheryl Patz
, RN, OCN, CCRC, at (360) 715-4133.